SavedAdd your journal

Journals / Türk Onkoloji Dergisi / 2016 / Cilt: 31 - Sayı: 3

Overview of Survival and Related Parameters in Malignancies with Brain Metastasis

Alpaslan MAYADAĞLI
Eda ERDİŞ
Birsen YÜCEL
Semiha URVAY
Pages
97–103
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therapeutic approaches should be planned with considerationthat patients exhibiting these characteristics might have more favorable therapeutic outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVEBrain metastasis is the most common type of brain tumor.
📊
Key Findings & Data:The present study is an investigation of prognosticfactors for survival in patients with brain metastasis.METHODSWe retrospectively investigated patients with brain metastasis who were treated at the Cumhuriyet Universitycenter for radiation oncology between 2006 and 2014.RESULTSThe data of 277 patients were analyzed.
💡
Conclusion & Impact:Therapeutic approaches should be planned with considerationthat patients exhibiting these characteristics might have more favorable therapeutic outcomes.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVEBrain metastasis is the most common type of brain tumor. The present study is an investigation of prognosticfactors for survival in patients with brain metastasis.METHODSWe retrospectively investigated patients with brain metastasis who were treated at the Cumhuriyet Universitycenter for radiation oncology between 2006 and 2014.RESULTSThe data of 277 patients were analyzed. Age of the patient, performance status, length of time to metastasis,site of primary disease, and performance of metastasectomy were determined to be factors that affectprognosis. Independent prognostic factors were found to be: time to metastasis (hazard ratio [HR]: 0.72;95% confidence interval [CI]: 0.52-0.99; p=0.0047), performance status (HR: 1.40; 95% CI: 1.07-1.85;p=0.015), and metastasectomy (HR: 0.54; 95% CI: 0.33-0.89; p=0.017).CONCLUSIONSurvival rate was better in patients with breast cancer, longer time before metastasis, good performance,and those who had undergone metastasectomy. Therapeutic approaches should be planned with considerationthat patients exhibiting these characteristics might have more favorable therapeutic outcomes.

🔖

Cite This Article

MAYADAĞLI, A., ERDİŞ, E., YÜCEL, B., URVAY, S. (2022). Overview of Survival and Related Parameters in Malignancies with Brain Metastasis. Türk Onkoloji Dergisi, Cilt: 31 - Sayı: 3, 97–103. https://ajindex.com/articles/639303

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, et al. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014;11(4):203,22
  2. Patchell RA. The management of brain metastases. Cancer Treat Rev 2003;29(6):533–40
  3. Campos S, Davey P, Hird A, Pressnail B, Bilbao J, Aviv RI, et al. Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma. Curr Oncol 2009;16(1):62–6
  4. Brem S, Panattil JG. An era of rapid advancement: diagnosis and treatment of metastatic brain cancer. Neurosurgery 2005;57(5 Suppl):5–9; discusssion 1–4
  5. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2008;75(1):5– 14
  6. Rodrigues G, Bauman G, Palma D, Louie AV, Mocanu J, Senan S, et al. Systematic review of brain metastases prognostic indices. Pract Radiat Oncol 2013;3(2):101– 6
  7. Rodrigues G, Gonzalez-Maldonado S, Bauman G, Senan S, Lagerwaard F. A statistical comparison of prognostic index systems for brain metastases af ter stereotactic radiosurgery or fractionated stereotactic radiation therapy. Clin Oncol (R Coll Radiol) 2013;25(4):227–35
  8. Yamamoto M, Kawabe T, Higuchi Y, Sato Y, Nariai T, Watanabe S, et al. Validity of prognostic grading indices for brain metastasis patients undergoing repeat radiosurgery. World Neurosurg 2014;82:1242–9
  9. Viani GA, da Silva LG, Stefano EJ. Prognostic indexes for brain metastases: which is the most powerful? Int J Radiat Oncol Biol Phys 2012;83(3):325–30. 10.Suh JH. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010;362(12):1119– 27. 11.Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, Morris RE, et al. The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96(1):17–32. 12.Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, Cobbs CS, et al. The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96(1):33,43. 13.Nieder C, Nestle U, Walter K, Niewald M, Schnabel K. Dose/effect relationships for brain metastases. J Cancer Res Clin Oncol 1998;124(6):346–50. 14.Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cance